Simcere Pharmaceutical Group Limited
€1.49
0
+€0+0% Friday 06:02
Statistics
Day High
1.49
Day Low
1.49
52W High
1.59
52W Low
0.89
Volume
0
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
21AugExpected
Expected EPS
N/A
Actual EPS
0.0319730741652
People Also Follow
This list is based on the watchlists of people on Stock Events who follow S2P.MU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. It focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. The company's principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; Softan, a rosuvastatin calcium tablet; ZAILIN, an amoxicillin granules/dispersible tablet/capsule; Iremod, an iguratimod tablet; Antine, a diclofenac sodium sustained release capsule/gel; and Orencia, an abatacept injection. It also offers promotion services for pharmaceutical products. Simcere Pharmaceutical Group Limited has a strategic regional licensing partnership with Vivoryon Therapeutics N.V. to develop and commercialize medicines targeting the neurotoxicity amyloid protein N3pE (pGlu-Aß) to treat Alzheimer's disease. The company was founded in 1995 and is headquartered in Nanjing, China.
Show more...
CEO
Mr. Jinsheng Ren
Employees
6542
Country
Hong Kong
ISIN
HK0000658531
Listings
0 Comments
Share your thoughts
FAQ
What is Simcere Pharmaceutical Group Limited stock price today?▼
The current price of S2P.MU is €1.49 EUR — it has increased by +0% in the past 24 hours. Watch Simcere Pharmaceutical Group Limited stock price performance more closely on the chart.
What is Simcere Pharmaceutical Group Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Simcere Pharmaceutical Group Limited stocks are traded under the ticker S2P.MU.
Is Simcere Pharmaceutical Group Limited stock price growing?▼
S2P.MU stock has risen by +0% compared to the previous week, the month change is a +14.62% rise, over the last year Simcere Pharmaceutical Group Limited has showed a +63.74% increase.
When is the next Simcere Pharmaceutical Group Limited earnings date?▼
Simcere Pharmaceutical Group Limited is going to release the next earnings report on August 21, 2026.
What were Simcere Pharmaceutical Group Limited earnings last quarter?▼
S2P.MU earnings for the last quarter are 0.03 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Simcere Pharmaceutical Group Limited have?▼
As of April 15, 2026, the company has 6,542 employees.
In which sector is Simcere Pharmaceutical Group Limited located?▼
Simcere Pharmaceutical Group Limited operates in the Health & Wellness sector.
When did Simcere Pharmaceutical Group Limited complete a stock split?▼
Simcere Pharmaceutical Group Limited has not had any recent stock splits.
Where is Simcere Pharmaceutical Group Limited headquartered?▼
Simcere Pharmaceutical Group Limited is headquartered in Nanjing, Hong Kong.